American International Group’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-50,466
| Closed | -$4.14M | – | 2639 |
|
2024
Q1 | $4.14M | Buy |
50,466
+2,672
| +6% | +$219K | 0.01% | 799 |
|
2023
Q4 | $889K | Sell |
47,794
-193
| -0.4% | -$3.59K | ﹤0.01% | 1364 |
|
2023
Q3 | $531K | Buy |
47,987
+1,707
| +4% | +$18.9K | ﹤0.01% | 1565 |
|
2023
Q2 | $750K | Buy |
+46,280
| New | +$750K | ﹤0.01% | 1402 |
|
2022
Q2 | – | Sell |
-33,963
| Closed | -$102K | – | 3272 |
|
2022
Q1 | $102K | Sell |
33,963
-2,391
| -7% | -$7.18K | ﹤0.01% | 2590 |
|
2021
Q4 | $167K | Sell |
36,354
-1,087
| -3% | -$4.99K | ﹤0.01% | 2465 |
|
2021
Q3 | $235K | Sell |
37,441
-890
| -2% | -$5.59K | ﹤0.01% | 2338 |
|
2021
Q2 | $230 | Buy |
38,331
+116
| +0.3% | +$1 | ﹤0.01% | 2420 |
|
2021
Q1 | $242 | Buy |
38,215
+101
| +0.3% | +$1 | ﹤0.01% | 2271 |
|
2020
Q4 | $215 | Sell |
38,114
-1,093
| -3% | -$6 | ﹤0.01% | 2252 |
|
2020
Q3 | $228K | Sell |
39,207
-892
| -2% | -$5.19K | ﹤0.01% | 2065 |
|
2020
Q2 | $289K | Buy |
40,099
+1,684
| +4% | +$12.1K | ﹤0.01% | 1906 |
|
2020
Q1 | $180K | Sell |
38,415
-2,219
| -5% | -$10.4K | ﹤0.01% | 1960 |
|
2019
Q4 | $326K | Sell |
40,634
-342
| -0.8% | -$2.74K | ﹤0.01% | 1930 |
|
2019
Q3 | $282K | Sell |
40,976
-285
| -0.7% | -$1.96K | ﹤0.01% | 1975 |
|
2019
Q2 | $342K | Buy |
41,261
+2,303
| +6% | +$19.1K | ﹤0.01% | 1917 |
|
2019
Q1 | $387K | Sell |
38,958
-526
| -1% | -$5.23K | ﹤0.01% | 1855 |
|
2018
Q4 | $302K | Buy |
39,484
+5,081
| +15% | +$38.9K | ﹤0.01% | 1947 |
|
2018
Q3 | $599K | Buy |
34,403
+6,036
| +21% | +$105K | ﹤0.01% | 1778 |
|
2018
Q2 | $269K | Buy |
+28,367
| New | +$269K | ﹤0.01% | 2197 |
|